Dignity Health and Aetna are in negotiations.
For more information, call 877-729-2669 or visit www.dignityhealth.org/aetna.
RESOLUTION
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults
Principal Investigator: Brian Tiffany, MD, PhD
https://clinicaltrials.gov/ct2/show/NCT04417257?term=resolution&cond=covid&draw=2&rank=2
For questions, please call 480-728-4425.
ACTIV-4 (NECTAR)- Novel Experimental COVID-19 Therapies Affection Host Response
Study to find effective strategies for inpatient management of patients with COVID-19.
Principal Investigator: Brian Tiffany, MD, PhD
https://clinicaltrials.gov/ct2/show/NCT04924660?term=ACTIV-4&recrs=a&draw=2&rank=3
For questions please call: 480-601-5411
ACTIV-6: COVID-19 study of Repurposed Medications
Study to evaluate the effectiveness of repurposed medications in reducing symptoms of non-hospitalized participants with mild to moderate COVID-19.
Principal Investigator: Brian Tiffany, MD, PhD
https://clinicaltrials.gov/ct2/show/NCT04885530?term=ACTIV-6&draw=2&rank=1
For questions please call: 480-601-5411
Nasal Swab collection for COVID-19 and flu A & B testing
This study aims to collect nasal swab samples from subjects with confirmed positive rapid test for COVID-19, flu A or flu B and subjects presenting with symptoms of those. Samples collected will be used for diagnostic research, product development and validation.
Principal Investigator: Brian Tiffany, MD, PhD
For questions please call: 480-601-5411
ExoFlow Phase III Stem Cell Derived Extracellular Vesicles for COVID-19
Trial to evaluate the efficacy fo ExoFlo in treating moderate to severe ARDS (Acute Respiratory Distress Syndrome) caused by COVID-19
Principal Investigator: Kristopher Roach, MD
https://clinicaltrials.gov/ct2/show/NCT05354141?term=exoflo&recrs=a&cond=COVID-19&draw=2&rank=1
For questions please call: 480-601-5411
Expanded Access Protocol for Stem Cell Derived Extracellular Vesicles for COVID-19
An expanded access protocol intended to provide ExoFlo to critically ill patients who do not qualify for the Phase III randomized control trial.
Principal Investigator: Kristopher Roach, MD
For questions please call: 480-601-5411
Arrhythmia
Cardiac Genomics
Coronary Artery Disease
Heart Failure
Structural Heart
Brain Tumors - Neuro Oncology
COVID-19
Infectious Disease
Peripheral Artery Disease
Point of Care
Stroke
Trauma
